Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 18 Source: CRO
- €662.9 million turnover
-
-€145.7 million
profit - 361 employees
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
- 6 more years available »
Ranking
By Turnover
(€662.9 million)- 127th in Top Companies
- 17th in Health
- 16th in Pharma
By Employees
(361)- 444th in Top Companies
- 67th in Health
- 45th in Pharma
-
- 361
- €662.9 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- Aug 05 Shannon campaigners demand board stands down
- Aug 05 Italy threatens Ryanair with flight ban for alleged Covid-19 violations
- Aug 05 Cork Airport passengers tumble to just 28,000
- Aug 05 European stocks close higher as commodities shares rally
- Aug 05 European stocks close higher as commodity shares rally